|
Title
|
|
|
|
Second line therapy in malignant pleural mesothelioma : a systematic review
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| After the implementation of standard first line chemotherapy with platinum and antifolates in pleural mesothelioma, patients are confronted with a need for second line treatment at relapse or progression. We conducted a systematic review of the literature for the activity, effectiveness and toxicity of second line treatment. The results are presented according to the class of drugs: chemotherapy and targeted or biological agent. (C) 2015 Elsevier Ireland Ltd. All rights reserved. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Lung cancer: journal of the International Association for the Study of Lung Cancer / International Association for the Study of Lung Cancer [Aurora, Colo.] - Amsterdam
|
|
|
Publication
|
|
|
|
Amsterdam
:
2015
|
|
|
ISSN
|
|
|
|
0169-5002
|
|
|
DOI
|
|
|
|
10.1016/J.LUNGCAN.2015.06.018
|
|
|
Volume/pages
|
|
|
|
89
:3
(2015)
, p. 223-231
|
|
|
ISI
|
|
|
|
000360513200001
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|